Global Dental Hub connects industry professionals, enterprises, and innovators to drive worldwide advancements in oral healthcare. Access verified company profiles, uncover cross-border opportunities, and leverage real-time market intelligence—all designed to accelerate the globalization of dental innovation. Join us in shaping a connected future for the industry.
TriCaFor® synthetic osteoplastic biomaterial, calcium-phosphate-based bone substitute materials, bioresorbable osteoconductive biomaterials, OctaFor® biomaterial, synthetic bone regeneration materials, bone defect filling materials, materials for dental implantology, sinus-lift and jawbone augmentation applications, materials for oral and maxillofacial surgery, biomaterials for traumatology and orthopedics, medical biomaterial R&D, manufacturing, professional product supply and online sales.
BioNova LLC (БиоНова) is a Russian medical biotechnology company specializing in the development, manufacture and commercialization of synthetic biomaterials designed for bone defect filling, bone regeneration and osteoplastic applications, with a particular focus on dentistry, implantology, oral and maxillofacial surgery, traumatology and orthopedics. The company's flagship product family is TriCaFor®, an osteoconductive, fully synthetic and bioresorbable calcium-phosphate-based biomaterial developed for the reconstruction and regeneration of bone tissue. According to published company and product materials, TriCaFor® was developed with an emphasis on creating a porous micro- and macro-structured architecture that can provide a suitable three-dimensional environment for bone ingrowth while gradually undergoing biological resorption. The material is positioned as an alternative to autografts, allografts and xenogeneic bone substitutes and has been investigated for the treatment of different types of bone defects. TriCaFor® has particular relevance to dentistry and maxillofacial surgery, including applications associated with dental implantation, sinus-lift procedures, treatment of jawbone defects and filling of postoperative bone cavities. Historical clinical materials report evaluation of TriCaFor® at a number of Russian medical and dental institutions, including the Central Research Institute of Dentistry and Maxillofacial Surgery and other specialized medical centers. In addition to dental applications, the company's materials have been presented for use in traumatology and orthopedics, including bone defects associated with orthopedic implants. BioNova operates through an online commercial platform at tricafor.ru, where its products are offered for professional and institutional purchase. Company documentation identifies BioNova LLC as the seller operating the TriCaFor online store and provides its Moscow corporate contact information. The company has also developed additional biomaterial products, including OctaFor®, reflecting its broader focus on synthetic bone-substitute technologies rather than a single dental product. The company's business model combines biomaterial research and development, medical-material manufacturing, product commercialization and professional application support. For international dental manufacturers and distributors, BioNova is particularly relevant as a Russian biomaterials manufacturer and potential technology/product partner in dental bone regeneration, implantology, oral surgery and maxillofacial applications. Its TriCaFor® product line may also be of interest to companies working with dental implant systems, guided bone regeneration, bone augmentation and other surgical procedures requiring synthetic bone-substitute materials.
Address：49 Leninsky Prospekt, Moscow, Russia.
Telephone： Click to get in touch
Email： Click to get in touch
Website：https://tricafor.ru/
Joining Date：2026-09-09 14:27:11
Countries and Regions：
Total page views：29
Want to start a conversation about cooperation? Click the cooperation consultation button above to explore cooperation opportunities together.
